Cite

HARVARD Citation

    Dougados, M. et al. (n.d.). 226 Summary of baricitinib effect on patient-reported outcomes (PROs) in methotrexate-inadequate responder patient population. Rheumatology. p. . [Online]. 
  
Back to record